Dentsply Sirona Inc. · NASDAQ:XRAY
Dentsply Sirona — Q2 2025 Earnings Presentation
21 slides from Dentsply Sirona's earnings presentation, Aug 7, 2025
Slide 1: Second Quarter 2025 Earnings Conference Call
Second Quarter 2025 August 7, 2025 Earnings Conference Call
Slide 2: Forward-Looking Statements and Associated Risks
Forward-Looking Statements and Associated Risks All statements in this Presentation that do not directly and exclusively relate to historical facts constitute "forward-looking statements." Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause ac
Slide 3: Near-Term Priorities
Near-Term Priorities Drive commercial execution Engage with stakeholders – observe, listen, and learn Stabilize organization through change Accelerate results through focused investment 3
Slide 4: Summary of Q2 Results
Summary of Q2 Results Net Sales Adj. EBITDA Margin Adj. EPS $936M 21.1% $0.52 (6.7%) 360 bps 6.6% Constant Currency YoY Expansion YoY Expansion YoY with a (3.2%) Byte Impact U.S. Net Sales Europe Net Sales Rest of World Net Sales $293M $404M Constant $239M Currency (18.3%) (18.3%) (0.4%) 0.5% Consta
Slide 5: Second Quarter 2025 Financial Summary
Second Quarter 2025 Financial Summary Q2 2025 Q2 2024 YoY Commentary ▪ Net sales in constant currency (6.7%) YoY Net Sales $936M $984M (4.9%) • Declines in CTS, OIS, and Wellspect Healthcare, partially offset by EDS • Byte sales impact (3.2%) Constant (6.7%) (2.3%) (440) bps ▪ Adj. EBITDA margin 21.
Slide 6: Second Quarter 2025 Segment Results
Second Quarter 2025 Segment Results Sales Commentary Essential Dental $387M Solutions Reported: +2.9% ▪ Growth in Rest of World, partially offset by lower volumes in Europe and the U.S. (EDS) Constant Currency: +1.1% Orthodontic and $226M ▪ Orthodontics (DD): Decline due to a ~($35M) Byte YoY impact
Slide 7: 2025 Outlook
2025 Outlook* Prior Outlook Current Outlook Comments Constant Currency (4.0%) to (2.0%) (4.0%) to (2.0%) Includes a (2.0%) Byte impact Reported Sales $3.60B - $3.70B $3.60B - $3.70B - Adjusted EBITDA Margin >19% >19% - Adjusted EPS $1.80 - $2.00 $1.80 - $2.00 - Reaffirmed FY2025 Outlook Constant cur
Slide 8: Summary
Summary 1 2 3 Q2 net sales on a constant Driving margin expansion Prioritizing customer currency basis (6.7%), through operational experience, stakeholder including (3.2%) Byte impact; improvements and financial engagement, organizational adj. EPS up 6.6% discipline stability, and focused investment
Slide 9: Appendix
Appendix Dentsply S Sirona
Slide 10: Leadership Transition
Leadership Transition Dan Scavilla, Chief Executive Officer; Joined August 1st, 2025 • Most recently served as President and CEO of Globus Medical, Inc.; has previously held a variety of financial and operational leadership roles at Globus Medical and Johnson & Johnson • Over 30 years of executive l
Slide 11: Our Strategy
Transform oral health and continence care by driving product Our Strategy and service innovation and delivering an exceptional customer and patient experience through an engaged and inclusive workforce Strategic Initiatives Achieve Annual Enhance & Accelerate Win in High Drive High Growth & Sustain
Slide 12: Trailing Nine Quarters
Trailing Nine Quarters In millions (except percentages) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Net Sales $1,028 $947 $1,012 $953 $984 $951 $905 $879 $936 Adjusted EBITDA(1) $185 $171 $173 $160 $173 $170 $128 $168 $197 Adj. EBITDA Margin %(1) 17.8% 18.3% 17.1% 16.8% 17.5% 17.9% 14.2% 1
Slide 13: Non-GAAP Financial Measures Definitions
Non-GAAP Financial Measures Definitions Constant Currency Adjusted Gross Profit and Margin The Company defines "constant currency" as the reported net sales adjusted for the impact of foreign currency Adjusted gross profit is computed by excluding from gross profit the impact of any of the above adj
Slide 14: Net Sales to Constant Currency Basis by Segment
Reconciliation of Non-GAAP Financial Measures Net Sales to Constant Currency Basis by Segment (unaudited) 14
Slide 15: Net Sales to Constant Currency Basis by Geographic Region
Reconciliation of Non-GAAP Financial Measures Net Sales to Constant Currency Basis by Geographic Region (unaudited) 15
Slide 16: Segment Adjusted Operating Income
Reconciliation of Non-GAAP Financial Measures Segment Adjusted Operating Income (unaudited) 16
Slide 17: Condensed Consolidated Statements of Operations Q2 2025
Reconciliation of Non-GAAP Financial Measures Condensed Consolidated Statements of Operations Q2 2025 (unaudited) 17
Slide 18: Condensed Consolidated Statements of Operations Q2 2024
Reconciliation of Non-GAAP Financial Measures Condensed Consolidated Statements of Operations Q2 2024 (unaudited) 18
Slide 19: Adjusted EBITDA Q2 2025 and Q2 2024
Reconciliation of Non-GAAP Financial Measures Adjusted EBITDA Q2 2025 and Q2 2024 (unaudited) 19
Slide 20: Adjusted Free Cash Flow and Calculation of Adjusted Free Cash Flow Conversion
Reconciliation of Non-GAAP Financial Measures Adjusted Free Cash Flow and Calculation of Adjusted Free Cash Flow Conversion (unaudited) 20
Slide 21: Slide 21